For research use only. Not for therapeutic Use.
Hydroxetamine(Cat No.:I028980)is a synthetic derivative of the psychoactive compound ketamine, often studied for its potential applications in anesthesia and mood disorders. It acts primarily as an NMDA (N-methyl-D-aspartate) receptor antagonist, similar to ketamine, leading to dissociative and anesthetic effects. Hydroxetamine is being researched for its potential in treating conditions such as depression, anxiety, and post-traumatic stress disorder (PTSD), with some studies suggesting it may have fast-acting antidepressant effects. However, due to its psychoactive properties, further studies are required to assess its safety, efficacy, and therapeutic applications.
Catalog Number | I028980 |
CAS Number | 1620054-73-0 |
Synonyms | Hydroxetamine; HXE; O-desmethyl Methoxetamine; 3-hydroxy-2-oxo-PCE; |
Molecular Formula | C14H19NO2 |
Purity | 98% |
Solubility | To be determined |
Appearance | Solid powder |
Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
IUPAC Name | 2-(ethylamino)-2-(3-hydroxyphenyl)cyclohexan-1-one |
InChI | InChI=1S/C14H19NO2/c1-2-15-14(9-4-3-8-13(14)17)11-6-5-7-12(16)10-11/h5-7,10,15-16H,2-4,8-9H2,1H3 |
InChIKey | CQERUJSORROCGH-UHFFFAOYSA-N |
SMILES | CCNC1(CCCCC1=O)C2=CC(=CC=C2)O |